Table 1. Clinical characteristics of study participants.
| CRSwNP | CRSsNP | Control | P-value | |
|---|---|---|---|---|
| Number of samples | 8 | 6 | 8 | - |
| Age (years) (median, (IQR)) | 48 (30.8) | 38 (27.3) | 48 (30.8) | 0.809 |
| Male/female | 3/5 | 5/1 | 4/4 | 0.222 |
| Atopy | 1/8 | 2/6 | 3/8 | 0.493 |
| Asthma | 2/8 | 0/6 | 0/8 | 0.146 |
| Smoking | 1/8 | 1/6 | 0/8 | 0.514 |
| Nasal steroid | 5/8 | 4/6 | 4/8 | 0.797 |
| Preoperative antibiotics (within 6 months) | 3/8 | 3/6 | 1/8 | 0.300 |
| Lund-Mackay score (median, (IQR)) | 11.0 (8.5) | 10.5 (12.0) | 0 (0) | 0.001 |
| Blood eosinophil % (median, (IQR)) | 4.2 (6.4) | 4.5 (2.3) | 3.0 (3.8) | 0.759 |
Abbreviations: CRSwNP, chronic rhinosinusitis with nasal polyp; CRSsNP, chronic rhinosinusitis without nasal polyp; IQR, interquartile range.